⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIOA News
BioAge Labs, Inc. Common Stock
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
BIOA
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
globenewswire.com
BIOA
BioArctic publishes the Annual Report and Sustainability Report for 2025 USA - English USA - English
prnewswire.com
BIOA
BioArctic publishes the Annual Report and Sustainability Report for 2025
prnewswire.com
BIOA
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
globenewswire.com
BIOA
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
BIOA
The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB USA - English USA - English
prnewswire.com
BIOA
Form 8-K
sec.gov
BIOA
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
prnewswire.com
BIOA
BIIB
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
BIOA